IL201901A0 - Controlled release tablet formulation containing magnesium aluminometasilicate - Google Patents

Controlled release tablet formulation containing magnesium aluminometasilicate

Info

Publication number
IL201901A0
IL201901A0 IL201901A IL20190109A IL201901A0 IL 201901 A0 IL201901 A0 IL 201901A0 IL 201901 A IL201901 A IL 201901A IL 20190109 A IL20190109 A IL 20190109A IL 201901 A0 IL201901 A0 IL 201901A0
Authority
IL
Israel
Prior art keywords
controlled release
formulation containing
containing magnesium
release tablet
tablet formulation
Prior art date
Application number
IL201901A
Other languages
English (en)
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of IL201901A0 publication Critical patent/IL201901A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL201901A 2007-05-17 2009-11-03 Controlled release tablet formulation containing magnesium aluminometasilicate IL201901A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0709541.7A GB0709541D0 (en) 2007-05-17 2007-05-17 Pharmaceutical excipient
PCT/IB2008/002128 WO2008142572A2 (en) 2007-05-17 2008-05-16 Controlled release tablet formulation containing magnesium aluminometasilicate

Publications (1)

Publication Number Publication Date
IL201901A0 true IL201901A0 (en) 2010-06-16

Family

ID=38234655

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201901A IL201901A0 (en) 2007-05-17 2009-11-03 Controlled release tablet formulation containing magnesium aluminometasilicate

Country Status (9)

Country Link
US (1) US20100196475A1 (enExample)
EP (1) EP2152248A2 (enExample)
JP (1) JP2010527347A (enExample)
CN (1) CN101677962B (enExample)
AU (1) AU2008252481B2 (enExample)
CA (1) CA2684366A1 (enExample)
GB (1) GB0709541D0 (enExample)
IL (1) IL201901A0 (enExample)
WO (1) WO2008142572A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660674T3 (es) * 2009-03-04 2018-03-23 Emplicure Ab Formulación resistente al abuso
CA2761000C (en) 2009-05-08 2018-05-29 Orexo Ab Composition for sustained drug delivery comprising geopolymeric binder
PL2540298T3 (pl) 2010-02-26 2016-04-29 Toray Industries Powlekany stały preparat
PL2613784T3 (pl) 2010-09-07 2018-05-30 Emplicure Ab Wyrób do przezskórnego podawania leku
CN104523627B (zh) * 2014-12-18 2017-04-12 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷片药物组合物及其制备方法
WO2016201119A1 (en) * 2015-06-09 2016-12-15 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
US10166185B2 (en) 2015-06-09 2019-01-01 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
CN109069770A (zh) * 2016-02-29 2018-12-21 埃姆普里居公司 用于蒸发和吸入尼古丁的装置
CN105769798A (zh) * 2016-05-16 2016-07-20 张阳 一种高血压治疗药物的制备方法
CN105997915A (zh) * 2016-05-16 2016-10-12 张阳 一种高血压治疗用缓释片剂
GB201714412D0 (en) 2017-09-07 2017-10-25 Emplicure Ab Evaporation devices containing plant material
CN114146061B (zh) * 2020-09-07 2023-06-30 歌礼生物科技（杭州）有限公司 包含固体分散体的蛋白酶抑制剂增效组合物及其制备方法
CN114149011A (zh) * 2020-09-08 2022-03-08 浙江丰虹新材料股份有限公司 一种药用辅料硅酸铝镁及其合成方法
EP4565202A1 (en) * 2022-04-01 2025-06-11 EMPLICURE AB (publ) Alkaline intraoral products

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
DE69207656T2 (de) * 1991-01-30 1996-10-17 The Wellcome Foundation Ltd., London Wasserlösliche tabletten
ATE260646T1 (de) * 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
JPH11286438A (ja) * 1998-03-31 1999-10-19 Shiseido Co Ltd 徐放性製剤
EP1140027B1 (en) * 1998-12-23 2005-10-12 Alza Corporation Dosage forms comprising porous particles
TW471968B (en) * 1999-08-25 2002-01-11 Committee On Chinese Medicine Solamargine pharmaceutical composition for killing cancer cells
HUP0300444A3 (en) * 2000-04-11 2007-09-28 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US20030203029A1 (en) * 2001-12-14 2003-10-30 Wong Patrick S.-L. Controlled release liquid active agent formulation dosage forms
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
EP1607092A4 (en) * 2003-03-17 2010-12-15 Takeda Pharmaceutical COMPOSITIONS WITH CONTROLLED RELEASE
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
AU2004294674B2 (en) * 2003-12-01 2009-02-26 Recordati Ireland Limited Pharmaceutical compositions comprising lercanidipine
JP3996626B2 (ja) * 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
KR101352299B1 (ko) * 2004-06-28 2014-02-17 벨로시스 파마슈티컬스 에이/에스 액상 제형용 담체로서의 다공성 정제
KR20070043894A (ko) * 2004-08-19 2007-04-25 알자 코포레이션 제어 방출형 나노입자 활성제 제제 제형 및 방법
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090124702A1 (en) * 2005-01-25 2009-05-14 Pechetti Siva Satya Krishna Babu Pharmaceutical Compositions of Metformin

Also Published As

Publication number Publication date
CN101677962A (zh) 2010-03-24
CA2684366A1 (en) 2008-11-27
AU2008252481B2 (en) 2014-05-01
JP2010527347A (ja) 2010-08-12
CN101677962B (zh) 2012-12-12
US20100196475A1 (en) 2010-08-05
AU2008252481A1 (en) 2008-11-27
WO2008142572A3 (en) 2009-02-12
EP2152248A2 (en) 2010-02-17
GB0709541D0 (en) 2007-06-27
WO2008142572A2 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
IL201901A0 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
EP2242485A4 (en) ORAL TABLET WITH CONTROLLED RELEASE
PT2345410T (pt) Composição farmacêutica para libertação modificada
ZA201003723B (en) Tablet dispenser
PT2498759T (pt) Formulações de comprimidos de libertação imediata
ZA200900314B (en) Controlled release granules
EP2392512A4 (en) TABLE DISPENSING DEVICE
EP2379059A4 (en) COMPOSITION WITH CONTROLLED RELEASE
ZA200908019B (en) Controlled release pharmaceutical compositions for prolonged effect
EG26318A (en) Fertilizer formulation from which the active ingredients are controlled
EP2315816A4 (en) CUTTING MATERIALS
GB2449505B (en) Tablet dispenser
ZA201103986B (en) Capecitabine rapidly distegrating tablets
ZA200908066B (en) Impermeable capsules
EP2124891A4 (en) CILOSTAZOL-CONTAINING PREPARATION WITH CONTROLLED RELEASE AND METHOD FOR THE PRODUCTION THEREOF
SI2040684T1 (sl) Večenotne tablete
IL205200A0 (en) Improved tablet coating
EP2296709A4 (en) NIACIN FORMULATIONS WITH MODIFIED RELEASE
ZA200904654B (en) Tablet formulation
SI2170348T1 (sl) Šumeče tablete za inhalacijsko uporabo
SI1952805T1 (sl) Tableta, ki vsebuje hidrogenirane fosfolipide
ZA201104564B (en) Low dosage controlled release tablet
HUP0700485A3 (en) Pharmaceutical composition with controlled release containing tolperisone
GB0605104D0 (en) Tablet dispenser
ZA200805980B (en) Fast release granules